Glucose-responsive biomimetic nanoreactor in bacterial cellulose hydrogel for antibacterial and hemostatic therapies

Anti-infections therapy accompanied with effective hemorrhage control is highly urgent in clinics. Herein, a biomimetic nanoreactor encapsulated self-healing hydrogel with glucose-responsive catalytic activity was constructed for synergetic antibacterial defense and hemostasis. A metal-organic frameworks (MOF)-based nanocatalyst loaded with glucose oxidase (GOx) was fabricated and encapsulated in the bacterial cellulose (BC) reinforced hydrogel, while the sustained release of GOx could catalyze the decomposition of glucose for triggering the MOF-mediated catalytic activity to in situ generate OH for bacteria killing. Importantly, this nanozyme-based hydrogel exhibited excellent hemostatic property owing to the enhanced absorption capacity, which provides the essential glucose from blood for triggering the glucose-responsive antibacterial activity simultaneously. Antibacterial tests revealed that the hydrogel exhibited significant antibacterial efficacy and biofilm inhibition ability in the presence of normal blood level of glucose. Such design of biocatalytic hydrogel for synergistic hemostatic and antibacterial application brings new insight for nanozyme-based biomedical therapies.